Glial Cell Line-Derived Neurotrophic Factor: A Novel Therapeutic Approach to Treat Motor Dysfunction in Parkinson's Disease
- 31 March 1997
- journal article
- review article
- Published by Elsevier in Experimental Neurology
- Vol. 144 (1) , 29-34
- https://doi.org/10.1006/exnr.1996.6384
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral deliveryNeuroscience, 1997
- Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseasesCell and tissue research, 1996
- Functional recovery in parkinsonian monkeys treated with GDNFNature, 1996
- Glial Cell Line‐Derived Neurotrophic Factor Exerts Neurotrophic Effects on Dopaminergic Neurons In Vitro and Promotes Their Survival and Regrowth After Damage by 1‐Methyl‐4‐PhenylpyridiniumJournal of Neurochemistry, 1996
- Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeysJournal of Comparative Neurology, 1995
- Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neuronsJournal of Comparative Neurology, 1995
- Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivoBrain Research Bulletin, 1995
- Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivoNeuroscience Letters, 1994
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993
- The Nigrostriatal Dopaminergic System Assessed In Vivo by Positron Emission Tomography in Healthy Volunteer Subjects and Patients With Parkinson's DiseaseArchives of Neurology, 1990